PharmaJet has completed a number of scientific studies, and is embarking on many new studies, all aimed at confirming not only that the device is just as effective as a needle and syringe, but better – that it saves on the volume of vaccine or creates a better immune response.

We have more than 16 collaborations with universities, manufacturers and governments underway worldwide. Vaccines currently under study include:

Hepatitis A, Hepatitis B, Hepatitis C, Rabies, Measles Mumps and Rubella (MMR), Tetanus, Tuberculosis (BCG), Dengue Fever, a cancer therapeutic, RNAi, Flu, Avian Flu, Small Pox, Monkey Pox, Avian Flu, West Nile, Foot & Mouth Disease, Avian New Castle, Malaria, Yellow Fever, Dengue Fever, Foot & Mouth Disease, Malaria, and HIV.

We’re also working to establish distribution channels in many countries to provide you with a needle-free alternative in your hospital or vaccine clinic.

Policies

The world’s leading health organizations – among them the World Health Organization, GAVI, PATH and CDC – have published clear policies concerning the desirability of needle-free technology.